A possible explanation that the researchers gave for this is that IL-2R is only found on regulatory T cells in tumor lesions with no significant change over time, which would mean that [18F]FB-IL2 does image IL-2R in the TME, but is not, however, a good biomarker for therapy response. The gene discussed is IL2RA; the disease is neoplasm.